首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Elevated free nitrotyrosine levels but not protein-bound nitrotyrosine or hydroxyl radicals throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
【2h】

Elevated free nitrotyrosine levels but not protein-bound nitrotyrosine or hydroxyl radicals throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant

机译:在整个肌萎缩性侧索硬化症(ALS)疾病中游离硝基酪氨酸水平升高但蛋白结合的硝基酪氨酸或羟基自由基未升高这暗示酪氨酸硝化是一种家族性的ALS连锁超氧化物歧化酶1突变体的异常体内特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in superoxide dismutase 1 (SOD1; EC 1.15.1.1) are responsible for a proportion of familial amyotrophic lateral sclerosis (ALS) through acquisition of an as-yet-unidentified toxic property or properties. Two proposed possibilities are that toxicity may arise from imperfectly folded mutant SOD1 catalyzing the nitration of tyrosines [Beckman, J. S., Carson, M., Smith, C. D. & Koppenol, W. H. (1993) Nature (London) 364, 584] through use of peroxynitrite or from peroxidation arising from elevated production of hydroxyl radicals through use of hydrogen peroxide as a substrate [Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., Gralla, E. D., Roe, J. A., Valentine, J. S. & Bredesen, D. E. (1996) Science 271, 515–518]. To test these possibilities, levels of nitrotyrosine and markers for hydroxyl radical formation were measured in two lines of transgenic mice that develop progressive motor neuron disease from expressing human familial ALS-linked SOD1 mutation G37R. Relative to normal mice or mice expressing high levels of wild-type human SOD1, 3-nitrotyrosine levels were elevated by 2- to 3-fold in spinal cords coincident with the earliest pathological abnormalities and remained elevated in spinal cord throughout progression of disease. However, no increases in protein-bound nitrotyrosine were found during any stage of SOD1-mutant-mediated disease in mice or at end stage of sporadic or SOD1-mediated familial human ALS. When salicylate trapping of hydroxyl radicals and measurement of levels of malondialdehyde were used, there was no evidence throughout disease progression in mice for enhanced production of hydroxyl radicals or lipid peroxidation, respectively. The presence of elevated nitrotyrosine levels beginning at the earliest stages of cellular pathology and continuing throughout progression of disease demonstrates that tyrosine nitration is one in vivo aberrant property of this ALS-linked SOD1 mutant.
机译:超氧化物歧化酶1(SOD1; EC 1.15.1.1)中的突变通过获得尚未确定的毒性特性而导致一定比例的家族性肌萎缩性侧索硬化症(ALS)。提出的两种可能性是,通过使用过氧亚硝酸盐,不完全折叠的突变型SOD1会催化酪氨酸的硝化而产生毒性[Beckman,JS,Carson,M.,Smith,CD&Koppenol,WH(1993)Nature(London)364,584]。或由于通过使用过氧化氢作为底物而增加了羟基自由基的产生引起的过氧化[Wiedau-Pazos,M.,Goto,JJ,Rabizadeh,S.,Gralla,ED,Roe,JA,Valentine,JS&Bredesen,DE (1996)Science 271,515–518]。为了测试这些可能性,在两只转基因小鼠中测量了硝基酪氨酸的水平和羟自由基形成的标志物,这些小鼠从表达人类家族性ALS连锁的SOD1突变G37R演变为进行性运动神经元疾病。相对于正常小鼠或表达高水平野生型人SOD1的小鼠,与最早的病理异常同时发生的脊髓中3-硝基酪氨酸水平升高了2到3倍,并且在整个疾病进展过程中脊髓中的3-硝基酪氨酸水平仍然保持升高。但是,在小鼠中SOD1突变介导的疾病的任何阶段或散发或SOD1介导的家族性人ALS的末期,都没有发现蛋白质结合的硝基酪氨酸增加。当使用水杨酸盐捕获羟基自由基并测量丙二醛水平时,没有证据表明在整个疾病进展过程中,分别有增强的羟基自由基产生或脂质过氧化作用的小鼠。从细胞病理学的最早阶段开始一直持续到疾病的整个发展过程,硝基酪氨酸水平的升高表明酪氨酸硝化是该ALS连接的SOD1突变体的一种体内异常特性。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号